BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22910499)

  • 1. Human papillomavirus vaccination and the primary prevention of cancer: implications for survivors of childhood cancer.
    Klosky JL; Foster RH; Hodges J; Peasant C; Gamble H; McDermott MJ; Rao P
    Stud Health Technol Inform; 2012; 172():33-42. PubMed ID: 22910499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus vaccination in survivors of childhood cancer.
    Klosky JL; Gamble HL; Spunt SL; Randolph ME; Green DM; Hudson MM
    Cancer; 2009 Dec; 115(24):5627-36. PubMed ID: 19813272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age considerations when vaccinating against HPV.
    Wright TC; Huh WK; Monk BJ; Smith JS; Ault K; Herzog TJ
    Gynecol Oncol; 2008 May; 109(2 Suppl):S40-7. PubMed ID: 18482558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.
    Julius JM; Ramondeta L; Tipton KA; Lal LS; Schneider K; Smith JA
    Pharmacotherapy; 2011 Mar; 31(3):280-97. PubMed ID: 21361739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and predictors of human papillomavirus (HPV) vaccination among young women surviving childhood cancer.
    Klosky JL; Favaro B; Peck KR; Simmons JL; Russell KM; Green DM; Hudson MM
    J Cancer Surviv; 2016 Jun; 10(3):449-56. PubMed ID: 26572902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cancer prevention in the human papilloma virus vaccine era.
    Ghazal-Aswad S
    Ann N Y Acad Sci; 2008 Sep; 1138():253-6. PubMed ID: 18837904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus vaccination in female pediatric cancer survivors.
    Hoffman L; Okcu MF; Dreyer ZE; Suzawa H; Bryant R; Middleman AB
    J Pediatr Adolesc Gynecol; 2012 Oct; 25(5):305-7. PubMed ID: 22831900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public health issues related to HPV vaccination.
    Hershey JH; Velez LF
    J Public Health Manag Pract; 2009; 15(5):384-92. PubMed ID: 19704306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations for cervical cancer prevention in Asia Pacific.
    Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
    Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
    Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A
    Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quadrivalent human papillomavirus vaccine.
    Barr E; Tamms G
    Clin Infect Dis; 2007 Sep; 45(5):609-7. PubMed ID: 17682997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
    Arbyn M; Dillner J
    J Clin Virol; 2007 Mar; 38(3):189-97. PubMed ID: 17258503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany].
    Schneider A; Schwarz TF; Hammerschmidt T; Siebert U
    Med Klin (Munich); 2007 Jul; 102(7):515-23. PubMed ID: 17634869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention strategies against the human papillomavirus: the effectiveness of vaccination.
    Stanley M
    Gynecol Oncol; 2007 Nov; 107(2 Suppl 1):S19-23. PubMed ID: 17938013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human papillomavirus (HPV) vaccine and cervical cancer: uptake and next steps.
    Sheinfeld Gorin SN; Glenn BA; Perkins RB
    Adv Ther; 2011 Aug; 28(8):615-39. PubMed ID: 21818672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress toward implementation of human papillomavirus vaccination--the Americas, 2006-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(40):1382-4. PubMed ID: 21993342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus vaccine: widening the scope for cancer prevention.
    No JH; Kim MK; Jeon YT; Kim YB; Song YS
    Mol Carcinog; 2011 Apr; 50(4):244-53. PubMed ID: 21465574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing cervical cancer through human papillomavirus vaccination: perspective from focus groups.
    Wong LP
    J Low Genit Tract Dis; 2009 Apr; 13(2):85-93. PubMed ID: 19387128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are we missing an opportunity for cancer prevention? Human papillomavirus vaccination for survivors of pediatric and young adult cancers.
    Temkin SM; Seibel NL
    Cancer; 2015 Oct; 121(19):3395-402. PubMed ID: 26110510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.